Related Experiment Video
Updated: Jun 11, 2026

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
Published on: January 29, 2019
A clinician's guide to AAV production - How manufacturing platforms shape vector properties
Jørgen Magnus1, Jonas Käsbach1
1RWTH Aachen University Institute of Biochemical Engineering Forckenbeckstr. 51 52074 Aachen Germany.
None:
Adeno-associated virus (AAV) has become the leading viral vector for in vivo gene therapy. This review examines how different manufacturing methods, from mammalian to insect cell-based systems, influence AAV vector characteristics. Though each platform generates vectors with distinct molecular signatures affecting purity, safety and potency, clinical outcomes remain consistent across production platforms. Understanding the nuances of these platforms will still provide valuable insight for clinicians overseeing AAV-based therapy.
More Related Videos
Related Concept Videos
Mass and Weight
Production of Formed Elements
Most HSCs commit to...
Mass and Weight
Specific Gravity of Aggregate
Bulk or gross specific gravity is calculated by taking the ratio of the mass of aggregates in the saturated surface-dry state to the total volume that includes both the solids and the voids within the...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Design Example: Managing Concrete Workability
To address...

